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Abstract: Goal: The olfactory region function disorders and olfactory bulb volume 
changes in neurodegenerative and neuropsychiatric disorders are defined. In this study, 
the olfactory bulb values of patients diagnosed with major depression in accordance with 
DMS-IV criteria, are measured with MRI, and these values are compared with the values 
of healthy volunteers to see if there are any statistically significant changes. Method: The 
study was carried out with 20 healthy volunteers and 20 patients who had been diagnosed 
with acute major depression in accordance with ‘diagnostic and statistical manual of 
mental disorders’ (DMS) IV criteria and have been getting treatment for more than 2 
years in Istanbul Education and Research Hospital. 1,5 Tesla MRI were used in 40 cases, 
and the olfactory bulb volume on two hemispheres were measured separately. Results: 
Contrary to the former studies, we found no statistically significant difference between 
the olfactory bulb volume measurements of the control group and the group diagnosed 
with major depression. 
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Introduction 
In the recent years, studies about olfactory 
bulb (OB) function and OB volume in 
neuropsychiatric disorders have become more 
and more frequent. It’s possible to examine the 
links between the limbic system, prefrontal 
cortex and olfactory region thanks to these 
studies (1, 6, 10). 
The most frequent type of neuropsychiatric 
disorder is major depression. Its average 
incidence rate is 2.6%-6.2%. Major depression 
is the most frequent disorder in psychiatry 
with its lifelong 15% of prevalence rate in the 
general society, and 25% of prevalence rate 
among women (4). Major depression is seen 
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twice as much among women, independent on 
culture or country of residence. The average 
age of onset for major depressive disorder is 
40, and 50% of the patients first suffer from it 
between the ages of 20-50 (4). Many reasons 
are defined for the development of major 
depressive disorder. The general opinion is 
that the cases with organic disorders are 
triggered by environmental causes. Studies 
revealed that neurotransmitter changes in 
brain, and damage in especially affection 
functioned cortex regions are among the 
causes for the development of the disorder. In 
recent years, with the help of studies about OB 
volume and function, it’s thought that the OB 
volume of patients with depressive affect have 
differences from the OB volume of a healthy 
brain (1, 6, 8, 10). 
In this study, we examined 20 cases 
diagnosed with major depression and 20 
healthy volunteers in terms of OB volumes 
using cranial magnetic resonance imaging, 
and we aimed to determine if there is a 
statistically significant difference between two 
groups. 
Materials and method 
This study was carried out between 2013-
2015 with the help of the psychiatry, radiology 
and neurosurgery clinics of Istanbul 
Education and Research Hospital. All patients 
took part in the study had given written 
consents and the ethics committee of the 
hospital had approved the study. 20 cases took 
part in the study; 14 males and 6 females, 
diagnosed with acute major depression in 
accordance with the ‘diagnostic and statistical 
manual of mental disorders’ (DMS) IV 
criteria, and getting treatment for 3 months in 
average. The neurological examinations of the 
patients were carried out. Then, with their eyes 
are closed, we used two pieces of scented 
cotton which does not damage the nasal 
mucosa to test their olfactory perceptions. 
This test was repeated with well-known (mint-
coffee etc.) scents and the patients were asked 
to define what they had smelled. The cases 
with anosmia and olfactory disorders were left 
out of the study. 
Before the neuroimaging stage, we had 
consulted the otorhinolaryngology clinic 
about the patients. The patients suffering from 
nasal problems such as septal deviation and 
sinusitis did not take part in the study. 
The control group consisting of 20 
patients, 10 females and 10 males had been 
chosen amongst the patients applied to the 
hospital for various reasons. Detailed 
neuropsychiatric examinations had been 
carried out before the study. Patients with 
former psychiatric complaints, psychiatric 
disorder history in the family and head trauma 
history had been removed from the study. All 
MR imaging work were done using 8 channel 
head-coil with GE 1,5 Tesla MR (GE, 2011, 
USA) device which belongs to Istanbul 
Education and Research Hospital. Each 
participant was examined with cranial MRI to 
exclude cranial organic disorders (5 mm thick-
standard section 3 dimensional [3D] 
sequence). 2 mm thick and – T2 weighted fast-
spin-echo imaging was run to observe the 
anterior and central skull base for the OB 
measurements (Figure 1). Olfactory bulb (OB) 
volume measurements were calculated 
separately on lamina cribriform anterior on 
  
 
 
 
100          Ozdemir et al          The changes of olfactory bulb volume in major depression 
 
 
 
 
 
 
 
each hemisphere. Following the methods used 
in former studies; the OB’s longest part and the 
length that forms a right angle to that part were 
multiplied, and the result were multiplied with 
the number of sections OB’s observed on; thus 
the volume measurements were finalized (5, 6, 
13).  
 
Figure 1 - OB measurements 
 
Statistical Analysis 
NCSS (Number Cruncher Statistical 
System) 2007&PASS (Power Analysis and 
Sample Size) 2008 Statistical Software (Utah, 
USA) program was used for statistical analysis. 
Descriptive statistical methods (centering, 
standard deviation, median, frequency, ratio, 
minimum, maximum) were used when 
analyzing the study data. Student’s t-test was 
used in order to analyze the relationship 
between variables. Significance level was 
observed as p<0,05. 
Results 
The study was carried out by measuring the 
OB volumes of 20 patients diagnosed with 
acute major depression; 14 being male (70%) 
and 6 being female (30%), and 20 volunteers; 
10 being male (50%) and 10 being female 
(50%) using cranial magnetic resonance 
imaging (MRI). The ages of the cases 
diagnosed with major depression varied 
between 17 to 65, with an average age of 38,1 
years. The ages of cases in the control group 
varied between 20 to 60, with an average age of 
34,5 years. The demographic attributes of the 
cases participated in the study is summarized 
(Table 1). 
The patients with major depression had 
three months of past medical history in 
average. 14 patients had been using selective 
serotonin reuptake inhibitors (SSRI: 
citalopram, escitalopram, paroxetine), 6 
patients had been using tricyclic 
antidepressants (mirtazapine, doxepine, 
trimipramine). 
The right and left OBs were measured 
separately for the patients in the depression 
group and the control group. Patients with 
major depression had an OB volume of 
39,15±12,82 mm3 in average for the right 
hemisphere, and 40,55±10,94 mm3 in average 
for the left hemisphere. Volumes varied 
between 14 mm3and 66 mm3 for the right 
hemisphere, and between 23 mm3and 61 mm3 
for the left hemisphere. Patients of control 
group had an OB volume of 35,39±10,89 mm3 
in average for the right hemisphere, and 
36,55±12,8 mm3 in average for the left 
hemisphere. Volumes varied between 22 
mm3and 59 mm3 for the right hemisphere, 
and between 22 mm3and 65 mm3 for the left 
hemisphere (Table 2). 
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TABLE 1 
The demographic attributes of the cases participated in the study 
Patients Number Female Male Age (Average) 
Major Depression 20 (50%) 6 14 38,1 (17-65) 
Control Group 20 (50%) 10 10 34,5 (20-60) 
Total 40 (100%) 16 (40%) 24 (60%) 36,3 (17-65) 
 
TABLE 2 
OB volume measurements of patients with major depression and control group 
Patients OB volume 
(Right) 
OB volume 
(Left) 
Range 
(Right) 
Range 
(Left) 
Major Depression 39,15±12,82 mm3 40,55±10,94 mm3 14 mm3-66 mm3 23 mm3-61 mm3 
Control Group 35,39±10,89 mm3 36,55±12,8 mm3 22 mm3-59 mm 3 22 mm3-65 mm3 
Total 37,27 mm3 (100%) 38,55 mm3 (100%) 14 mm3-66 mm3 22 mm3-65 mm3 
 
There was no statistically significant 
difference found when the OB volume 
measurements were compared separately for 
the right and the left hemisphere of the major 
depression group and the control group 
p˃0,05. 
Patients with major depression were split 
into two groups in terms of the type of 
medication they used. The two groups using 
medications with different active ingredients 
were first compared with each other 
statistically. There was no statistically 
significant difference found between patients 
using medications with different active 
ingredients.  
Discussion 
Depression is considered a frequent type of 
disorder and named as a public health problem 
in developed and developing communities. 
Because it’s so frequent, most neuroscientists 
are interested in its causes. In the last two 
decades, it’s revealed that neurotransmitter 
pathways pave the way for and speed up the 
formation of many psychiatric disorders. 
Having said that, some parts and regions of the 
brain have very important tasks regarding 
cognitive function and mood. Prefrontal 
cortex and the limbic system form close 
relations with each other, thus, affect the 
clinical course and medication response (3, 6). 
With functional MRI coming into the 
picture, in neuropsychiatric disorders, we can 
now examine and reveal the parts of the brain 
where there is a loss of function. Brain imaging 
studies in major depression cases have been 
also carried out for years. We often see 
imaging studies mainly focusing on the frontal 
lobe which mostly deals with emotion 
regulation. Personality changes often seen in 
cases dealing with frontal lobe trauma or 
frontal tumors prove the significance of the 
frontal lobe (2). 
Studies in the recent years revealed that OB 
function losses cause a tendency to depression 
and may cause changes in medication 
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response. OB is an area that lies just below 
cribriform plate, in anterior cranial fossa with 
a 36,44±12,8 mm3average volume (7). It has 
fibers reaching out to thalamus. 
In 2001, the study by Pause et al. detected 
reduced olfactory volume and reduced 
olfactory sensitivity. There are many theories 
aiming to explain olfactory deficit seen in 
major depression. Pause et al. thought that the 
disinhibition in amygdala that affects 
emotional responses were in fact responsible 
for olfactory deficit. The abnormal 
functioning in the paralimbic cortex 
(especially amygdala and orbitofrontal cortex) 
were the main reasons for the concurrent early 
period olfactory area disinhibition in major 
depression cases (11). In 2010, with their 
studies, Negoias et al. determined for the first 
time that depression score is correlated with 
olfactory function and volume (8). 
Olfactory area volume and functions may 
also change due to psychiatric and 
neurodegenerative disorders. Major 
depression and schizophrenia may be the 
cause of function or volume loss (7, 9, 11, 12, 
14, 16). In addition to these, volume deficit 
and functional disorders may also be 
determined in multiple sclerosis and 
Parkinson’s disease cases (15). Not all cases of 
olfactory volume loss indicate a 
neuropsychiatric disorder. Head trauma, 
sinonasal diseases, infections and upper 
respiratory pathologies may also cause 
changes in measurements. OB may function as 
a neurotransmitter. Early period changes may 
also act as precursor symptom (7, 12). 
 
Conclusion 
In our study, we measured the olfactory 
bulb volumes of major depression cases using 
neuroimaging, compared the findings with 
those of healthy volunteers and the results are 
examined to find out whether there is a 
statistically significant difference between 
them. Contrary to the findings in former 
studies, we could not find any statistically 
significant difference. Further studies with 
more patients are needed in order to come to a 
definite conclusion. 
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